J. Goldman & CO LP Insmed Inc Transaction History

J. Goldman & CO LP

$3.21 Billion
Q3 2024

A detailed history of J. Goldman & CO LP transactions in Insmed Inc stock. As of the latest transaction made, J. Goldman & CO LP holds 11,226 shares of INSM stock, worth $874,280. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,226

Previous 20,000 43.87%

Holding current value

$874,280

Previous $1.34 Million 38.88%

% of portfolio

0.03%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $696,012 - $886,966	11,226 New	11,226 $819,000
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $200,435 - $233,322	-7,793 Reduced 29.96%	18,221 $494,000
Q4 2023 Feb 14, 2024	SELL	$23.42 - $31.74 $15,152 - $20,535	-647 Reduced 2.43%	26,014 $806,000
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $170,418 - $231,086	8,581 Added 47.46%	26,661 $673,000
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $7,217 - $9,262	439 Added 2.49%	18,080 $381,000
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $254,029 - $339,487	-15,623 Reduced 46.97%	17,641 $300,000
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $2.55 Million - $3.48 Million	-150,383 Reduced 81.89%	33,264 $664,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $3.83 Million - $5.18 Million	183,647 New	183,647 $3.96 Million
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $781,011 - $1.09 Million	-33,957 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$13.91 - $31.15 $1.49 Million - $3.34 Million	-107,336 Reduced 75.97%	33,957 $987,000
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $1.64 Million - $2.64 Million	141,293 New	141,293 $1.85 Million
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $868,042 - $1.29 Million	-45,807 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$20.0 - $29.72 $4.39 Million - $6.52 Million	-219,316 Reduced 82.72%	45,807 $1.08 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $5.32 Million - $8.09 Million	245,229 Added 1232.68%	265,123 $5.97 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $1.79 Million - $2.16 Million	-67,894 Reduced 77.34%	19,894 $620,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $1.02 Million - $2.74 Million	87,788	87,788 $2.74 Million

Others Institutions Holding INSM

# of Institutions

480

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.32M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Account